Medium materiality6/10
Pharvaris price target raised to $46 from $41 at Morgan Stanley
Why it may matterVerify against the original reporting
Upside potential
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley lifts PHVS target to $46; current price about $33.29.
- Target $46 vs $33.29; ~38% upside.
Key facts
- 01
Target: $46
- 02
Posted price: $33.29
- 03
Analyst firm: Morgan Stanley
- 04
Analyst: Maxwell Skor
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.